SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Mergers & acquisitions
Alkermes’ up to $2.1B Purchase of Avadel Sets Groundwork for ‘Strategic Evolution’
With Avadel under its fold, Alkermes expects to accelerate its expansion into the sleep market, laying the foundation for its late-stage narcolepsy asset alixorexton.
October 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Facade of Moderna's building in Massachusetts
Vaccines
Moderna Scraps CMV Vaccine After Phase III Fail
A key question for investors going forward will be whether Moderna’s other latent virus vaccines for Epstein-Barr and shingles can succeed after the failure of the CMV program.
October 23, 2025
 · 
3 min read
 · 
Tristan Manalac
Photo of scientists and legal counsel in meeting
Job Trends
8 Companies Hiring Now in Regulatory
Looking for a job in regulatory? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
October 23, 2025
 · 
2 min read
 · 
Angela Gabriel
Illustration of two businessmen with one person’s silhouette showing a Pinocchio nose, signaling dishonesty
Job Trends
Posers and Pretenders: Interview Fraud Rising, Experts Say
Biopharma professionals have become increasingly likely to be dishonest when interviewing for jobs, based on BioSpace interviews with three talent acquisition experts. The experts discuss the reasons why as well as the types of fraud happening, including people posing as applicants.
October 23, 2025
 · 
5 min read
 · 
Angela Gabriel
IN PARTNERSHIP WITH ECLIPSEBIO
Webinar: The Future of mRNA Medicine: How Advanced Data Empowers Cures
October 22, 2025
 · 
1 min read
 · 
BioSpace Insights
Hands reach out to each other. Handshake. Halftone retro hands. Body parts cut out of newspaper. Hands tied with thread. Shaking hands. Make a deal. Successful agreement. Modern collage
Mergers & acquisitions
Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody
The deal focuses on ICT01, a monoclonal antibody being tested in acute myeloid leukemia. ImCheck is also developing assets in infectious disease and other oncology indications.
October 22, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Exclusive magazine collage image of hand hold flag yuan euro dollar currency trade war bank usa europe china economy embargo.
Drug pricing
Trump To Target Trading Partners With Drug Pricing Probe: Report
While the threat of tariffs dies down for the pharma industry, President Donald Trump is reportedly weighing a new investigation that could result in import taxes against U.S. trading partners that don’t pay enough for drugs.
October 22, 2025
 · 
1 min read
 · 
Annalee Armstrong
Illustration of scales of justice tipping to one side
Job Trends
Most Employers Consider Hiring but Worry About Overqualified Job Candidates: Survey
Seven in 10 U.S. hiring managers say their company usually considers employing overqualified applicants, according to a survey from Express Employment Professionals and The Harris Poll. However, 75% of employers believe such hires struggle to stay motivated in lower-level roles.
October 22, 2025
 · 
3 min read
 · 
Angela Gabriel
Museum island on Spree river and Alexanderplatz TV tower in center of Berlin, Germany
Cancer
ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin
Pfizer, Merck, AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ESMO, with antibody-drug conjugates, bispecific antibodies and kinase inhibitors demonstrating encouraging efficacy and safety for various cancers.
October 22, 2025
 · 
4 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS